Nonenzymatic glycation: A central mechanism in diabetic microvasculopathy?

Journal of Diabetic Complications

Volumn 2, Issue 4, 1988, Pages 214-217

  Cohen, Margo P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN;

BLOOD; DIABETIC ANGIOPATHY; GLYCOSYLATION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

BLOOD PROTEINS; DIABETIC ANGIOPATHIES; GLYCOSYLATION; HUMAN;

EID: 0024101325     PISSN: 08916632     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-6632(88)80012-6     Document Type: Review

References (53)

1. Hemoglobin components in patients with diabetes mellitus
2. 1c: Slow glycosylation of hemoglobin in vivo
3. Increased glycosylation of glomerular basement membrane collagen in diabetes
4. ∈-amino-lysine-bound glucose in human tissues obtained at autopsy: Increase in diabetes mellitus
5. Nonenzymatic glycosylation of basement membrane collagen in diabetes mellitus
6. Glycosylation in vivo of human lens capsule (basement membrane) and diabetes mellitus
7. Nonenzymatic glucosylation of lysyl and hydroxylysyl residues in Type I and Type II collagens
8. The nonenzymatic glycosylation of collagen
9. Nonenzymatic glycosylation of basement membranes. In vitro studies
10. Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen
11. Apparent accelerated aging of human collagen in diabetes mellitus
12. Modification of glomerular basement membrane crosslinks in experimental diabetic rats
13. Influence of in vitro nonenzymatic glucosylation on the physico-chemical parameters of Type I collagen
14. Effect of in vitro nonenzymatic glucosylation on Type I collagen fibrillogenesis
15. Inhibition of collagen fibril formation in vitro and subsequent crosslinking by glucose
16. Thermal stability mechanical properties and reducible crosslinks of rat tail tendon in experimental diabetes
17. The thermal stability of collagen in diabetic rats: Correlation with severity of diabetes and nonenzymatic glycosylation
18. Collagen aging in vitro by nonenzymatic glycosylation and browning
19. Thermal stability of collagen in relation to nonenzymatic glycosylation and browning in vitro
20. Nonenzymatic glycosylation and the pathogenesis of diabetic complications
21. Detection of nonenzymatic browning products in the human lens
22. Evidence for glucose mediated covalent crosslinking of collagen after glycosylation in vitro
23. Aging of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose
24. Nonenzymatic glucosylation and glucose dependent crosslinking of protein
25. Preparation and analysis of the products of nonenzymatic protein glycosylation and their relationship to crosslinking of proteins
26. Nonenzymatic glycosylation products on collagen covalently trap low density lipoproteins
27. Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen: Role in the in situ formation of immune complexes
28. Increased concentration of albumin in kidney basement membranes in diabetes mellitus
29. Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation
30. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus
31. Decreased interaction of fibronectin, Type IV collagen, and heparin due to nonenzymatic glycation. Implication for diabetes mellitus
32. Glycosylation of human LDL and its metabolism in human skin fibroblasts
33. Interaction of human endothelial cells with elevated glucose concentrations and native and glycosylated low density lipoproteins
34. Glycosylation of LDL decreases its ability to interact with high affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo
35. Metabolism of nonenzymatic glycosylated low density lipoprotein by mini pig aortic endothelial cells
36. Impaired hepatocyte binding, uptake and degradation of glucosylated low density lipoproteins
37. Measurement of receptor independent metabolism of low density lipoproteins: An application of glucosylated low density lipoproteins
38. Glucosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism
39. Nonenzymatic glycosylation of low density lipoproteins: Evidence for in vitro and in vivo glycosylation
40. Metabolism of glycosylated very low density lipoproteins in human skin fibroblasts
41. Relation between complications of Type I diabetes mellitus and collagen-linked fluorescence
42. Accelerated age-related browning of collagen in diabetes mellitus
43. Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation end products
44. Recognition and uptake of human diabetic peripheral nerve myelin by macrophages
45. High-affinity receptor-mediated uptake and degradation of glucose modified proteins: A potential mechanism for removal of senescent macromolecules
46. Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus
47. Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy
48. Nonenzymatic glycosylation of skin collagen in patients with Type I (insulin-dependent) diabetes mellitus and limited joint mobility
49. Glycation of skin collagen in Type I diabetes mellitus. Correlation with long-term complications
50. Prevalence of macro- and micro-vascular disease as related to glycosylated hemoglobin in Type I and II diabetic subjects. An epidemiologic study in Denmark
51. Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking